Skip to Main Content

Non-Coding RNA, Blood Formation & Cell Fate - The Lu Lab at Yale School of Medicine

May 14, 2026

Transcript

  • 00:05Many RNAs inside ourselves,
  • 00:08now we recognize as functioning in a non-coding way.
  • 00:11The meaning of non-coding means
  • 00:13they are not for producing proteins,
  • 00:15but they're doing something else,
  • 00:17and so we're starting to study what these RNA molecules
  • 00:20are doing inside the cells and also inside the bodies.
  • 00:27My lab has two major angles of study.
  • 00:29One angle study is to study non-coding RNAs in the blood cell system
  • 00:34And there's a particular type of non-coding RNA we’re studying currently,
  • 00:37it’s the so-called glycosidic RNA.
  • 00:39But it basically means the RNA is sugar coated.
  • 00:42So it basically has a sugar modification on the RNA molecules,
  • 00:45and these modification enables RNA molecules
  • 00:49to do things that normal RNA molecules cannot do.
  • 00:52So that's one aspect of it that's very interesting.
  • 00:54The second aspect of it is almost all RNA inside our body are housed inside the cell.
  • 01:00But these RNAs actually appear many times on cell surface
  • 01:04on the outside cell surface of cells,
  • 01:06which is again a very unusual place where they're supposed to be.
  • 01:09So my lab was the first one to show a major function for this group of RNA.
  • 01:14They actually control blood cells,
  • 01:16how blood cells migrate inside the body in a significant way
  • 01:20and now we are really studying their relationship in disease settings,
  • 01:25how they controlling disease and how can we can potentially use them
  • 01:28as a therapeutic target or be used somehow
  • 01:32towards a therapy for human disease.
  • 01:35The second area we're studying is what kind of information
  • 01:38we can extract from the morphology aspect of tissues or cells.
  • 01:42What is the shape of this cell telling us about,
  • 01:46you know, this particular sample or this particular condition?
  • 01:50We studied neutrophils and looking at the shape of the cells
  • 01:53versus what they can potentially tell us in terms of what they're doing,
  • 01:56and it's amazing that, you know, there are quite some diseases.
  • 02:01We know that these cells look different from other normal conditions.
  • 02:05Yet we have very little clue what those shapes are actually telling us
  • 02:08and now our research is actually starting to uncover this link between
  • 02:14these abnormal cell shapes versus what they are potentially doing to the body.
  • 02:22What my lab does is we
  • 02:24try to use the best technology to address specific questions we have in mind,
  • 02:29and in some cases, we have to develop our own technologies.
  • 02:32One example is when we are studying the sugar coated RNA
  • 02:36because it’s a new field, the methodologies are quite limiting.
  • 02:40So to do anything that's going to be interesting,
  • 02:42we, many times, had to invent new techniques to do those things,
  • 02:46and that's something also, my lab is actually working on to develop those techniques.
  • 02:55For the sugar coated RNA, for example,
  • 02:57one thing we're looking at is how these RNAs are dysregulated in disease settings,
  • 03:02especially in other autoimmune diseases,
  • 03:06because many of these cells we’re studying is immune cells.
  • 03:09We also looking at the cancer relationship as well.
  • 03:12In that sense, the second aspect is to look at
  • 03:15whether they can be used as a way, as a target for therapies.
  • 03:20So we're developing new ways to perturb them,
  • 03:22or new ways to get rid of them or enhance them.
  • 03:26In those ways, we're trying to develop new strategies for disease treatments.